Grunenthal (Branded Product Portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Grunenthal (Branded Product Portfolio) General Information

Description

14 own and licensed brands in Eastern Europe and the Middle East. The products include Tramal, Zaldiar, Transtec and Palexia currently sold in the contract area in Russia, Bosnia, Latvia, Estonia, Saudi Arabia, Kuwait, Lebanon, Jordan, the United Arab Emirates, Egypt, Yemen, Oman, Bahrain and Qatar.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Zieglerstraße 6
  • 52078 Aachen
  • Germany
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Zieglerstraße 6
  • 52078 Aachen
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Grunenthal (Branded Product Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Grunenthal (Branded Product Portfolio)‘s full profile, request access.

Request a free trial

Grunenthal (Branded Product Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Grunenthal (Branded Product Portfolio)‘s full profile, request access.

Request a free trial

Grunenthal (Branded Product Portfolio) FAQs

  • Where is Grunenthal (Branded Product Portfolio) headquartered?

    Grunenthal (Branded Product Portfolio) is headquartered in Aachen, Germany.

  • What industry is Grunenthal (Branded Product Portfolio) in?

    Grunenthal (Branded Product Portfolio)’s primary industry is Buildings and Property.

  • Is Grunenthal (Branded Product Portfolio) a private or public company?

    Grunenthal (Branded Product Portfolio) is a Private company.

  • What is the current valuation of Grunenthal (Branded Product Portfolio)?

    The current valuation of Grunenthal (Branded Product Portfolio) is .

  • What is Grunenthal (Branded Product Portfolio)’s current revenue?

    The current revenue for Grunenthal (Branded Product Portfolio) is .

  • Who are Grunenthal (Branded Product Portfolio)’s investors?

    Grünenthal has invested in Grunenthal (Branded Product Portfolio).

  • When was Grunenthal (Branded Product Portfolio) acquired?

    Grunenthal (Branded Product Portfolio) was acquired on 31-Jan-2012.

  • Who acquired Grunenthal (Branded Product Portfolio)?

    Grunenthal (Branded Product Portfolio) was acquired by STADA Arzneimittel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »